Skip to main content
Erschienen in: European Child & Adolescent Psychiatry 2/2014

01.02.2014 | Editorial

Understanding the neuro-developmental pathogenesis of social disability: towards a cross-disorder approach

verfasst von: Catherine Barthélémy

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Excerpt

Early and persistent impairment in social interaction characterizes autism; it has always defined the condition’s core, from Kanner’s first description up to the latest DSM-5 criteria [1]. …
Literatur
1.
Zurück zum Zitat American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Washington DC American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Washington DC
2.
Zurück zum Zitat Hernandez N, Metzger A, Magné R, Bonnet-Brilhault F, Roux S, Barthélémy C, Martineau J (2009) Exploration of core features of a human face by healthy and autistic adults analyzed by visual scanning. Neuropsychologia 47(4):1004–1012CrossRefPubMed Hernandez N, Metzger A, Magné R, Bonnet-Brilhault F, Roux S, Barthélémy C, Martineau J (2009) Exploration of core features of a human face by healthy and autistic adults analyzed by visual scanning. Neuropsychologia 47(4):1004–1012CrossRefPubMed
3.
Zurück zum Zitat Dapretto M, Davies MS, Pfeifer JH, Scott AA, Sigman M, Bookheimer SY, Iacoboni M (2006) Understanding emotions in others: mirror neuron dysfunction in children with autism spectrum disorders. Nat Neurosci 9(1):28–30CrossRefPubMedCentralPubMed Dapretto M, Davies MS, Pfeifer JH, Scott AA, Sigman M, Bookheimer SY, Iacoboni M (2006) Understanding emotions in others: mirror neuron dysfunction in children with autism spectrum disorders. Nat Neurosci 9(1):28–30CrossRefPubMedCentralPubMed
4.
Zurück zum Zitat Gervais H, Belin P, Boddaert N, Leboyer M, Coez A, Sfaello L, Barthélémy C, Brunelle F, Samson Y, Zilbovicius M (2004) Abnormal cortical voice processing in autism. Nat Neurosci 7(8):801–802CrossRefPubMed Gervais H, Belin P, Boddaert N, Leboyer M, Coez A, Sfaello L, Barthélémy C, Brunelle F, Samson Y, Zilbovicius M (2004) Abnormal cortical voice processing in autism. Nat Neurosci 7(8):801–802CrossRefPubMed
5.
Zurück zum Zitat Cattaneo L, Fabbri-Destro M, Boria S, Pieraccini C, Monti A, Cossu G, Rizzolatti G (2007) Impairment of actions chains in autism and its possible role in intention understanding. Proc Natl Acad Sci USA 104(45):17825–17830CrossRefPubMed Cattaneo L, Fabbri-Destro M, Boria S, Pieraccini C, Monti A, Cossu G, Rizzolatti G (2007) Impairment of actions chains in autism and its possible role in intention understanding. Proc Natl Acad Sci USA 104(45):17825–17830CrossRefPubMed
6.
Zurück zum Zitat Cossu G, Boria S, Copioli C, Bracceschi R, Giuberti V, Santelli E, Gallese V (2012) Motor representation of actions in children with autism. PLoS One 7(9):e44779CrossRefPubMedCentralPubMed Cossu G, Boria S, Copioli C, Bracceschi R, Giuberti V, Santelli E, Gallese V (2012) Motor representation of actions in children with autism. PLoS One 7(9):e44779CrossRefPubMedCentralPubMed
8.
Zurück zum Zitat Cholemkery H, Kitzerow J, Rohrmann S, Freitag CM (2014) Validity of the social responsiveness scale to differentiate between autism spectrum disorders and disruptive behaviour disorders. Eur Child Adolesc Psychiatry. doi:10.1007/s00787-013-0427-5 (this issue) Cholemkery H, Kitzerow J, Rohrmann S, Freitag CM (2014) Validity of the social responsiveness scale to differentiate between autism spectrum disorders and disruptive behaviour disorders. Eur Child Adolesc Psychiatry. doi:10.​1007/​s00787-013-0427-5 (this issue)
9.
10.
Zurück zum Zitat Andari E, Duhamel JR, Zalla T, Herbrecht E, Leboyer M, Sirigu A (2010) Promoting social behaviour with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci USA 107(9):4389–4394CrossRefPubMed Andari E, Duhamel JR, Zalla T, Herbrecht E, Leboyer M, Sirigu A (2010) Promoting social behaviour with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci USA 107(9):4389–4394CrossRefPubMed
11.
Zurück zum Zitat Gordon I, Vander Wyk BC, Bennett RH, Cordeaux C, Lucas MV, Eilbott JA, Zagoory-Sharon O, Leckman JF, Feldman R, Pelphrey KA (2013) Oxytocin enhances brain function in children with autism. Proc Natl Acad Sci USA. doi:10.1073/pnas.1312857110 Gordon I, Vander Wyk BC, Bennett RH, Cordeaux C, Lucas MV, Eilbott JA, Zagoory-Sharon O, Leckman JF, Feldman R, Pelphrey KA (2013) Oxytocin enhances brain function in children with autism. Proc Natl Acad Sci USA. doi:10.​1073/​pnas.​1312857110
12.
Zurück zum Zitat Adamo N, Huo L, Adelsberg S, Petkova E, Castellanos FX, Di Martino A (2014) Response time intra-subject variability: commonalities between children with autism spectrum disorders and children with ADHD. Eur Child Adolesc Psychiatry. doi:10.1007/s00787-013-0428-4 (this issue) Adamo N, Huo L, Adelsberg S, Petkova E, Castellanos FX, Di Martino A (2014) Response time intra-subject variability: commonalities between children with autism spectrum disorders and children with ADHD. Eur Child Adolesc Psychiatry. doi:10.​1007/​s00787-013-0428-4 (this issue)
13.
Zurück zum Zitat Van der Meer JM, Oerlemans AM, van Steijn DJ, Lappenschaar MG, de Sonneville LM, Buitelaar JK, Rommelse NN (2012) Are autism spectrum disorder and attention-deficit/hyperactivity disorder different manifestations of one overarching disorder? Cognitive and symptom evidence from a clinical and population-based sample. J Am Acad Child Adolesc Psychiatry 51(11):1160–1172CrossRefPubMed Van der Meer JM, Oerlemans AM, van Steijn DJ, Lappenschaar MG, de Sonneville LM, Buitelaar JK, Rommelse NN (2012) Are autism spectrum disorder and attention-deficit/hyperactivity disorder different manifestations of one overarching disorder? Cognitive and symptom evidence from a clinical and population-based sample. J Am Acad Child Adolesc Psychiatry 51(11):1160–1172CrossRefPubMed
14.
Zurück zum Zitat Rommelse NN, Franke B, Geurts HM, Hartman CA, Buitelaar JK (2010) Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder. Eur Child Adolesc Psychiatry 19(3):281–295CrossRefPubMedCentralPubMed Rommelse NN, Franke B, Geurts HM, Hartman CA, Buitelaar JK (2010) Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder. Eur Child Adolesc Psychiatry 19(3):281–295CrossRefPubMedCentralPubMed
15.
Zurück zum Zitat Fatemi SH, Halt AR, Stary JM, Kanodia R, Schulz SC, Realmuto GR (2002) Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol Psychiatry 52(8):805–810CrossRefPubMed Fatemi SH, Halt AR, Stary JM, Kanodia R, Schulz SC, Realmuto GR (2002) Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol Psychiatry 52(8):805–810CrossRefPubMed
16.
Zurück zum Zitat Rout UK, Mungan NK, Dhossche DM (2012) Presence of GAD65 autoantibodies in the serum of children with autism or ADHD. Eur Child Adolesc Psychiatry 21(3):141–147CrossRefPubMed Rout UK, Mungan NK, Dhossche DM (2012) Presence of GAD65 autoantibodies in the serum of children with autism or ADHD. Eur Child Adolesc Psychiatry 21(3):141–147CrossRefPubMed
17.
Zurück zum Zitat Hegvik TA, Husebye ES, Haavik J (2014) Autoantibodies targeting neurotransmitter biosynthetic enzymes in attention-deficit/hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry. doi:10.1007/s00787-013-0429-3 (this issue) Hegvik TA, Husebye ES, Haavik J (2014) Autoantibodies targeting neurotransmitter biosynthetic enzymes in attention-deficit/hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry. doi:10.​1007/​s00787-013-0429-3 (this issue)
18.
Zurück zum Zitat Ben-Ari Y, Khalilov I, Kahle KT, Cherubini E (2012) The GABA excitatory/inhibitory shift in brain maturation and neurological disorders. Neuroscientist 18(5):467–486CrossRefPubMed Ben-Ari Y, Khalilov I, Kahle KT, Cherubini E (2012) The GABA excitatory/inhibitory shift in brain maturation and neurological disorders. Neuroscientist 18(5):467–486CrossRefPubMed
19.
Zurück zum Zitat Lemonnier E, Degrez C, Phelep M, Tyzio R, Josse F, Grandgeorge M, Hadjikhani N, Ben-Ari Y (2012) A randomised controlled trial of bumetanide in the treatment of autism in children. Transl Psychiatry 11(2):e202. doi:10.1038/tp.2012.124 CrossRef Lemonnier E, Degrez C, Phelep M, Tyzio R, Josse F, Grandgeorge M, Hadjikhani N, Ben-Ari Y (2012) A randomised controlled trial of bumetanide in the treatment of autism in children. Transl Psychiatry 11(2):e202. doi:10.​1038/​tp.​2012.​124 CrossRef
20.
Zurück zum Zitat Lemonnier E, Robin G, Degrez C, Tyzio R, Grandgeorge M, Ben-Ari Y (2013) Treating fragile X syndrome with the diuretic bumetanide: a case report. Acta Paediatr 102(6):e288–e290CrossRefPubMed Lemonnier E, Robin G, Degrez C, Tyzio R, Grandgeorge M, Ben-Ari Y (2013) Treating fragile X syndrome with the diuretic bumetanide: a case report. Acta Paediatr 102(6):e288–e290CrossRefPubMed
Metadaten
Titel
Understanding the neuro-developmental pathogenesis of social disability: towards a cross-disorder approach
verfasst von
Catherine Barthélémy
Publikationsdatum
01.02.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Child & Adolescent Psychiatry / Ausgabe 2/2014
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-013-0516-5

Weitere Artikel der Ausgabe 2/2014

European Child & Adolescent Psychiatry 2/2014 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

08.05.2024 Psychotherapie Nachrichten

Sportliche Betätigung hilft nicht nur bei Depression, sondern auch in Gruppen von Patientinnen und Patienten mit unterschiedlichen psychischen Erkrankungen, wie Insomnie, Panikattacken, Agoraphobie und posttraumatischem Belastungssyndrom. Sie alle profitieren längerfristig.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.